Experiment 534269
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV INFUSION |
| Organism | Empty organism |
| Citation | JAYSON,GC: CROWTHER,D: PRENDIVILLE,J: MC GOWN,AT: SCHEID,C: STERN,P: YOUNG,R: BRENCHLEY,P: CHANG,J: OWENS,S: PETTIT,GR:. (1995). A PHASE I TRIAL OF BRYOSTATIN 1 IN PATIENTS WITH ADVANCED MALIGNANCY USING A 24 HOUR INTRAVENOUS INFUSION.. 72(2) |
| Amount utilized | |
| Compound isolated | |
| Disease | IN 19 PATIENTS WITH ADVANCED MALIGNANCY. INCREASE OF IL-2-INDUCED PROLIFERATIVE RESPONSE IN PERIPHERAL BLOOD LYMPHOCYTES AND ENHANCED LAK ACTIVITY. ALSO MODULATION OF PKC ACTIVITY. |
| Dose amount | 25.0 MCG |
| Number | 3 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M |
| Dose expression | MAXIMUM TOLERATED DOSE |
| Gender | GIVEN TO BOTH SEXES |